Glycorex Transplantation
3,37
SEK
-5,6 %
GTAB B
NGM Main Regulated
Biotechnology & Pharmaceuticals
Health Care
Mindre end 1K følgere
-5,6%
+65,2%
+84,15%
+110,62%
+307%
+140,71%
-61,92%
-68,8%
-66,81%
Glycorex Transplantation is a biotechnology company. The company conducts research, development, and marketing within the field of organ transplantation. The main product of the company, Glycosorb-ABO, enables transplants irrespective of the blood type of the donors and the recipients. Transplants with the help of the company's product have been carried out worldwide. Glycorex Transplantation was founded in 1996 and is based in Lund.
Læs mereMarkedsværdi
248,89 mio. SEK
Aktieomsætning
561,47 t SEK
Omsætning
29,96 mio.
EBIT %
-101,07 %
P/E
-
Udbytteafkast, %
-
Finanskalender
27.2
2025
Årsrapport '24
23.5
2025
Delårsrapport Q1'25
27.5
2025
Generalforsamling '25
ViserAlle indholdstyper
Glycorex Transplantation AB (GTAB B): Results from Norwegian platelet evaluation presented at conference
Glycorex Transplantation AB: First ABO-incompatible transplantation in Argentina with Glycosorb® ABO
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools